Overview

Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis

Status:
Completed

Trial end date:
2007-05-01

Target enrollment:

Participant gender:

Summary

The primary objective is to assess differences in PASI scores between Week 12 of Study C87040 [NCT00245765] and Week 12 of re-treatment in this study.

Phase:

Phase 2

Details

Lead Sponsor:

UCB Pharma

Treatments:

Certolizumab Pegol